Loading…
Employees: 1,505
Size Baolingbao Biology (002286.SZ) is a China Consumer Staples company (Food: Specialty/Candy) with a market value of $500M, the 3869th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥8.77 on 6 Nov 2026.
Performance Over six months the shares fell 14.7%, against -9.3% for the median peer and -16.4% for the China market (cap-weighted) — 10th lowest of 21 in its peer set.
Growth Revenue grew 8.9% over the last twelve months (peer median +5.4%); the operating margin is 5.6% (peer median 6.0%).
Valuation It trades at 18.1× forward earnings against a peer median of 17.6× (6th most expensive of 14).
Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.3 points below its cost of capital (7.5% WACC).
Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥2.85B | CN¥2.74B | CN¥2.40B | CN¥2.52B | CN¥2.71B |
| Revenue growth | — | +15% | -5% | -7% | — |
| Gross profit | CN¥381M | CN¥344M | CN¥267M | CN¥182M | CN¥276M |
| EBITDA | CN¥293M | CN¥303M | CN¥277M | CN¥189M | CN¥266M |
| Net income | CN¥140M | CN¥151M | CN¥111M | CN¥54.0M | CN¥133M |
| Free cash flow | CN¥200M | CN¥158M | CN¥89.4M | CN¥133M | -CN¥218M |
| Capital expenditure | CN¥243M | CN¥189M | CN¥190M | CN¥152M | CN¥255M |
| Total debt | CN¥313M | CN¥178M | CN¥304M | CN¥354M | CN¥531M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002286.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.8% | -2.9% | 7th highest of 21 |
| 6-month return | -14.7% | -9.3% | 10th lowest of 21 |
| Distance from 52-week high | -25.0% | -27.9% | 11th highest of 21 |
| Revenue growth (TTM) | +8.9% | +5.4% | 7th highest of 21 |
| Operating margin | 5.6% | 6.0% | 9th lowest of 21 |
| Forward P/E | 18.1× | 17.6× | 6th most expensive of 14 |
| Growth the price implies (Req g, 7 yrs) | 10.0% | 3.9% | 6th most demanding of 17 |
| Growth delivered (Del g) | +6.0% | +5.6% | 8th highest of 17 |
| Hurdle (Req g minus delivered) | +4.0 pp | -4.0 pp | 4th most demanding of 17 |
| ROIC minus cost of capital | -2.3 pp | +1.3 pp | 3rd lowest of 21 |
| EV / EBITDA | 11.4× | 6.1× | 5th most expensive of 12 |
| Net debt / EBITDA | 0.0× | -0.1× | 6th most indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Baolingbao Biology 002286.SZ | China | $500M | -15% | +9% | 6% | 18.1× | 10.0% | +6.0% |
| Riken Vitamin 4526.T | Japan | $516M | +29% | +3% | 7% | 11.8× | -3.9% | +4.4% |
| Kameda Seika 2220.T | Japan | $525M | -8% | +17% | 6% | 18.0× | 0.3% | +6.0% |
| Nitto Fuji Flour Milling 2003.T | Japan | $472M | +14% | 0% | 6% | n/a | 3.0% | +5.2% |
| Ganso 603886.SS | China | $464M | +1% | +5% | 6% | 11.4× | -11.0% | -1.9% |
| Vadilal Industries VADILALIND.NS | India | $541M | +53% | +31% | 16% | n/a | 17.3% | +26.5% |
| Daesang 001680.KS | South Korea | $459M | -16% | +2% | 4% | 8.1× | -5.6% | +7.2% |
| Ganyuan Foods 002991.SZ | China | $552M | -22% | 0% | 10% | 17.1× | 4.8% | +12.4% |
| Bourbon 2208.T | Japan | $451M | +3% | +7% | 6% | 20.4× | -12.1% | +0.3% |
| Zhengzhou Qianweiyangchu Food 001215.SZ | China | $451M | -34% | +13% | 5% | 42.5× | 13.9% | +15.0% |
| Haoxiangni Health Food 002582.SZ | China | $558M | -21% | -17% | -11% | n/a | n/a | n/a |
| Petpal Pet Nutrition Technology 300673.SZ | China | $444M | -26% | +2% | 6% | 45.6× | 7.5% | +1.6% |
| Yasho Industries YASHO.NS | India | $441M | +122% | +35% | 14% | n/a | 33.4% | +17.7% |
| Apple Flavor & Fragrance 603020.SS | China | $570M | -7% | +3% | 4% | n/a | 16.4% | -1.5% |
| Shoei Foods 8079.T | Japan | $435M | +1% | +8% | 4% | 17.6× | n/a | n/a |
| Zhongjing Food 300908.SZ | China | $579M | -31% | +6% | 19% | 19.7× | 6.9% | +8.3% |
| Gourmet Master 2723.TW | Taiwan | $431M | +19% | -11% | 5% | 14.8× | 0.9% | -1.7% |
| Ligao Foods 300973.SZ | China | $604M | -19% | +5% | 7% | 17.1× | n/a | n/a |
| Kunshan Asia Aroma 301220.SZ | China | $413M | -35% | +13% | 6% | 24.8× | 10.8% | +12.4% |
| Tianshui Zhongxing Bio-Technology 002772.SZ | China | $410M | -54% | +12% | 14% | n/a | n/a | n/a |
| QAF Q01.SI | Singapore | $408M | -10% | 0% | 6% | n/a | -10.6% | +2.4% |